Skip to main content
Log in

Antiepileptika-Osteopathie oder Schmid-Kruse-Syndrom

Antiepileptica-induced osteopathy or Schmid-Kruse syndrome

  • Verschiedenes
  • Published:
Zeitschrift für Epileptologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Krämer G (2005) Knochenstoffwechsel und Epilepsie (Editorial). Z Epileptol 18:151

    Article  Google Scholar 

  2. Pack AM, Olarte LS, Morrell MJ et al (2003) Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav 4:169–174

    Article  PubMed  Google Scholar 

  3. Vestergaard P, Rejnmark L, Mosekilde L (2004) Fracture risk associated with the use of antiepileptic drugs. Epilepsia 45:1330–1337

    Article  CAS  PubMed  Google Scholar 

  4. Verrotti A, Coppola G, Parisi P et al (2010) Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg 112:1–10

    Article  PubMed  Google Scholar 

  5. Phabphal K, Geater A, Limapichat K et al (2013) Effect of switching hepatic enzyme-inducer antiepileptic drug to levetiracetam on bone mineral density, 25 hydroxyvitamin D, and parathyroid hormone in young adult patients with epilepsy. Epilepsia 54:e94–e98

    Article  CAS  PubMed  Google Scholar 

  6. Beniczky SA, Viken J, Jensen LT, Andersen NB (2012) Bone mineral density in adult patients treated with various antiepileptic drugs. Seizure 6:471–472

    Article  Google Scholar 

  7. Hakami T, OʼBrien T, Petty S et al (2011) Levetiracetam vs. older antiepileptic drugs: a randomized prospective bone health study. Endocr Rev 32(Suppl 3):P2-145

    Google Scholar 

  8. Steinhoff B (2010) Nachruf auf Rolf Kruse. Z Epileptol 23:133

    Article  Google Scholar 

  9. Krämer G (2012) Lexikon der Epileptologie. Hippocampus, Bad Honnef, S 780–781

  10. Offermann G, Pinto V, Kruse R (1979) Antiepileptic drugs and vitamin D supplementation. Epilepsia 20:3–15

    Article  CAS  PubMed  Google Scholar 

  11. Steinhoff BJ, Kruse R (1992) Bromide treatment of pharmaco-resistant epilepsies with generalized tonic-clonic seizures: a clinical study. Brain Dev 14:144–149

    Article  CAS  PubMed  Google Scholar 

  12. Kruse R (1966) Das myoklonisch-astatische Petit mal. Eine Verlaufsform kleiner epileptischer Anfälle des Kindesalters. Monografien aus dem Gesamtgebiete der Neurologie und Psychiatrie, Heft 124. Springer, Berlin Heidelberg New York Tokio

  13. Matthes A, Kruse R (Hrsg) (1973) Neuropädiatrie. Thieme, Stuttgart

  14. http://www.aerzteblatt.de/archiv/5157/Gestorben

  15. Schmid F (1967) Osteopathien bei antiepileptischer Dauerbehandlung. Fortschr Med 85:381–382

    Google Scholar 

  16. Opitz H, Schmid F (Hrsg) (1961–71) Handbuch der Kinderheilkunde. Springer, Berlin Heidelberg New York Tokio

  17. Schmid F, unter Mitarbeit von Schuster W, Beduhn D, Fuchs G et al (1973) Pädiatrische Radiologie. Lehrbuch in 2 Bänden. Springer, Berlin Heidelberg New York Tokio

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. G. Krämer gibt an, dass kein Interessenkonflikt besteht. Dieser Beitrag enthält keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Krämer.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krämer, G. Antiepileptika-Osteopathie oder Schmid-Kruse-Syndrom. Z. Epileptol. 27, 209–210 (2014). https://doi.org/10.1007/s10309-014-0386-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10309-014-0386-y

Navigation